Navigation Links
Rensselaer researcher wins prestigious American Cancer Society award for work on cancer
Date:10/14/2010

Troy, N.Y. A recent Research Scholar Grant from the American Cancer Society acknowledges the potential of Rensselaer researcher Lee Ligon's work on breast cancer. Ligon is investigating interactions between cells as breast cancer spreads within the body.

"We're trying to figure out how cancerous and non-cancerous cells communicate with each other, how they bind to each other, and what the consequences of those interactions are," Ligon said.

The Research Scholar Grant from the American Cancer Society includes a four-year $720,000 award to support this research.

"The Research Scholar Grant is a highly prestigious award for junior faculty. This grant acknowledges the importance of Dr. Ligon's work in the field of cancer research and heralds a promising future of valuable insights and discoveries," said Susan Gilbert, a Rensselaer professor and head of the department of biology.

Ligon studies cadherins, proteins that cause cells to adhere to one another, allowing cells to form organs and other structures. Different cadherins are expressed by different cells, each for its proper function.

"Cells have to stick together appropriately and if they express the same cadherin they will," Ligon said. "But that only works in the normal situation when cells are sticking to cells that they're supposed to stick to. We're interested in the situation in tumors."

More than 90 percent of all cancers, Ligon said, originate in epithelial cells cells that form barriers between the inside and outside of the body, like skin cells, or the cells that line the intestines, or milk ducts in the breasts.

Because epithelial cells form a barrier between the inside and outside of the body, they must renew themselves more frequently than many other kinds of cells like muscle or nerve cells. That presents more opportunity for abnormal cell division and cancer.

Most breast cancers originate in the epithelial cells that line milk ducts. In the early stages of the disease, the epithelial cells begin to grow abnormally, but are still confined within the lining of the milk ducts. At that point, the cancerous growth can still be excised with a surgeon's knife.

But with continued growth, the cancerous cells break through the barrier between the lining and the surrounding tissue the stroma at which point they come into contact with a different type of cell called fibroblasts. Now the cancer is progressing into the body. Unchecked, it will reach the bloodstream at which point it becomes far more difficult to treat.

"Normally fibroblasts live in stroma, epithelial cells live in ducts, and they never make physical contact. They don't come into contact with one another until there is pathological situation cancerous cells have broken the membrane, and invaded the stroma," Ligon said. "When that happens, they run into each other and we don't know much about the consequences of that contact between epithelial cells and fibroblasts."

In an earlier study, Ligon found that cancerous epithelial cells and fibroblasts do adhere to one another, despite expressing different cadherins.

"Everyone thought they wouldn't stick together, but when we introduced mildly invasive cancerous epithelial cells to normal fibroblasts, a certain percentage stick together," Ligon said.

"What we don't know is whether that will happen with normal epithelial cells or more invasive cancerous epithelial cells and fibroblasts," Ligon said. Those questions will form the basis for her next series of experiments, in which Ligon will introduce cancerous epithelial cells of varying invasiveness to healthy fibroblasts and observe the outcome.

Ligon said the results of her experiments could shed light on another puzzle: Whether her early results in which the cancerous epithelial cells and healthy fibroblasts did adhere bode ill or good for the patient.

"It is possible that this adhesion to these local cells is a good thing, in that it may be a barrier to stop metastasis. It's also possible that it will cause these cells to be more invasive," Ligon said.


'/>"/>

Contact: Mary Martialay
martim12@rpi.edu
518-276-2146
Rensselaer Polytechnic Institute
Source:Eurekalert

Related biology news :

1. Rensselaer professors Dordick and Interrante named ACS Fellows
2. Purifying proteins: Rensselaer researchers use NMR to improve drug development
3. Rensselaer professor uncovers mysterious workings of cholera bacteria
4. Left or right? Early clues to soccer penalty kicks revealed at Rensselaer Polytechnic Institute
5. Rensselaer Polytechnic Institute professor Peter M. Tessier named Pew Scholar
6. Rensselaer Polytechnic Institute professor Patrick Underhill receives NSF CAREER award
7. Rensselaer Polytechnic Institute wins $2.45 million grant to support stem cell research
8. Rensselaer researchers to send bacteria into orbit aboard space shuttle Atlantis
9. Rensselaer leads effort to replace 1 of the most widely used drugs in American hospitals
10. Rensselaer receives more than $2 million from New York State to fund stem cell research
11. Trustee makes donation to start new solar energy research center at Rensselaer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/25/2016)... , Jan. 25, 2016  Glencoe Software, the world-leading ... and publication industries, will provide the data management solution ... (NPSC). ... Phenotypic analysis measures the ... organisms, allowing comparisons between states such as health and ...
(Date:1/20/2016)... Jan. 20, 2016 A market that just ... benefit from the explosion in genomics knowledge. Learn all ... Research. A range of dynamic trends are pushing market ... personalized medicine - pharmacogenomics - pathogen evolution - next ... markets - greater understanding of the role of genetic ...
(Date:1/15/2016)... Puerto Rico , Jan. 15, 2016 ... big and small to find new ways to ensure ... culture. iOS and Android ... based on biometrics, transforming it into a hardware authorization ... that users swipe their fingerprint on their KodeKey enabled ...
Breaking Biology News(10 mins):
(Date:2/10/2016)... 2016  The Maryland House of Delegates and House ... University of Maryland School of Medicine Dean E. ... Maryland Medical System President and CEO Robert Chrencik ... highest honor given to the public by the leader ... Reece and Mr. Chrencik for their contributions to ...
(Date:2/10/2016)... 2016 ASAE is introducing a hybrid membership ... (AMC) the option of joining or renewing through an ... by staff size, every employee in any size association ... reap all available member benefits.   John ... membership options will allow organizations of any size and ...
(Date:2/10/2016)... -- IsoRay, Inc. (NYSE MKT: ISR), a medical technology company ... for the treatment of prostate, brain, lung, head and ... for the second quarter and six months of fiscal ... --> --> Revenue was $1.19 ... ended December 31, 2015, a 12% increase compared to ...
(Date:2/10/2016)... , Feb. 10, 2016  Matchbook, Inc., ... for fast growing biotech companies, announced today the ... Procurement Strategic Advisor. Jim brings nearly 25 years ... and procurement, having spent nearly two decades in ... Chain/Logistics and Procurement at Genzyme and, most recently ...
Breaking Biology Technology: